[email protected]
Int'l: +1(917)-997-2424
+91 916-916-4321
TRACK YOUR ORDER
CART ITEM
(0)
HOME
ABOUT US
REPORTS STORE
CONTACT US
Search by Text
Search by Report Code
Search
Home
Customize Purchase
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Report 2024(Status and Outlook)
Chapter/Section Purchase
Back to Report
Leave This Empty:
Report Title:-
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Report 2024(Status and Outlook)
Choose Chapter/Section to Purchase
Chapter/Section 1
Chapter/Section 2
Chapter/Section 3
Chapter/Section 4
Chapter/Section 5
Chapter/Section 6
Chapter/Section 7
Chapter/Section 8
Chapter/Section 9
Chapter/Section 10
Chapter/Section 11
Chapter/Section 12
Chapter/Section 13
Chapter/Section 14
Chapter/Section 15
Full Name
*
:
Business Email
*
:
Company Name
*
:
Contact Number
*
:
Country
*
:
Select Country
Afghanistan (+93)
Albania (+355)
Algeria (+213)
American Samoa (+1684)
Andorra (+376)
Angola (+244)
Anguilla (+1264)
Antarctica (+0)
Antigua and Barbuda (+1268)
Argentina (+54)
Armenia (+374)
Aruba (+297)
Australia (+61)
Austria (+43)
Azerbaijan (+994)
Bahamas (+1242)
Bahrain (+973)
Bangladesh (+880)
Barbados (+1246)
Belarus (+375)
Belgium (+32)
Belize (+501)
Benin (+229)
Bermuda (+1441)
Bhutan (+975)
Bolivia (+591)
Bosnia and Herzegovina (+387)
Botswana (+267)
Bouvet Island (+0)
Brazil (+55)
British Indian Ocean Territory (+246)
Brunei Darussalam (+673)
Bulgaria (+359)
Burkina Faso (+226)
Burundi (+257)
Cambodia (+855)
Cameroon (+237)
Canada (+1)
Cape Verde (+238)
Cayman Islands (+1345)
Central African Republic (+236)
Chad (+235)
Chile (+56)
China (+86)
Christmas Island (+61)
Cocos (Keeling) Islands (+672)
Colombia (+57)
Comoros (+269)
Congo (+242)
Congo, the Democratic Republic of the (+242)
Cook Islands (+682)
Costa Rica (+506)
Cote D'Ivoire (+225)
Croatia (+385)
Cuba (+53)
Cyprus (+357)
Czech Republic (+420)
Denmark (+45)
Djibouti (+253)
Dominica (+1767)
Dominican Republic (+1809)
Ecuador (+593)
Egypt (+20)
El Salvador (+503)
Equatorial Guinea (+240)
Eritrea (+291)
Estonia (+372)
Ethiopia (+251)
Falkland Islands (Malvinas) (+500)
Faroe Islands (+298)
Fiji (+679)
Finland (+358)
France (+33)
French Guiana (+594)
French Polynesia (+689)
French Southern Territories (+0)
Gabon (+241)
Gambia (+220)
Georgia (+995)
Germany (+49)
Ghana (+233)
Gibraltar (+350)
Greece (+30)
Greenland (+299)
Grenada (+1473)
Guadeloupe (+590)
Guam (+1671)
Guatemala (+502)
Guinea (+224)
Guinea-Bissau (+245)
Guyana (+592)
Haiti (+509)
Heard Island and Mcdonald Islands (+0)
Holy See (Vatican City State) (+39)
Honduras (+504)
Hong Kong (+852)
Hungary (+36)
Iceland (+354)
India (+91)
Indonesia (+62)
Iran, Islamic Republic of (+98)
Iraq (+964)
Ireland (+353)
Israel (+972)
Italy (+39)
Jamaica (+1876)
Japan (+81)
Jordan (+962)
Kazakhstan (+7)
Kenya (+254)
Kiribati (+686)
Korea, Democratic People's Republic of (+850)
Korea, Republic of (+82)
Kuwait (+965)
Kyrgyzstan (+996)
Lao People's Democratic Republic (+856)
Latvia (+371)
Lebanon (+961)
Lesotho (+266)
Liberia (+231)
Libyan Arab Jamahiriya (+218)
Liechtenstein (+423)
Lithuania (+370)
Luxembourg (+352)
Macao (+853)
Macedonia, the Former Yugoslav Republic of (+389)
Madagascar (+261)
Malawi (+265)
Malaysia (+60)
Maldives (+960)
Mali (+223)
Malta (+356)
Marshall Islands (+692)
Martinique (+596)
Mauritania (+222)
Mauritius (+230)
Mayotte (+269)
Mexico (+52)
Micronesia, Federated States of (+691)
Moldova, Republic of (+373)
Monaco (+377)
Mongolia (+976)
Montserrat (+1664)
Morocco (+212)
Mozambique (+258)
Myanmar (+95)
Namibia (+264)
Nauru (+674)
Nepal (+977)
Netherlands (+31)
Netherlands Antilles (+599)
New Caledonia (+687)
New Zealand (+64)
Nicaragua (+505)
Niger (+227)
Nigeria (+234)
Niue (+683)
Norfolk Island (+672)
Northern Mariana Islands (+1670)
Norway (+47)
Oman (+968)
Pakistan (+92)
Palau (+680)
Palestinian Territory, Occupied (+970)
Panama (+507)
Papua New Guinea (+675)
Paraguay (+595)
Peru (+51)
Philippines (+63)
Pitcairn (+0)
Poland (+48)
Portugal (+351)
Puerto Rico (+1787)
Qatar (+974)
Reunion (+262)
Romania (+40)
Russian Federation (+70)
Rwanda (+250)
Saint Helena (+290)
Saint Kitts and Nevis (+1869)
Saint Lucia (+1758)
Saint Pierre and Miquelon (+508)
Saint Vincent and the Grenadines (+1784)
Samoa (+684)
San Marino (+378)
Sao Tome and Principe (+239)
Saudi Arabia (+966)
Senegal (+221)
Serbia and Montenegro (+381)
Seychelles (+248)
Sierra Leone (+232)
Singapore (+65)
Slovakia (+421)
Slovenia (+386)
Solomon Islands (+677)
Somalia (+252)
South Africa (+27)
South Georgia and the South Sandwich Islands (+0)
Spain (+34)
Sri Lanka (+94)
Sudan (+249)
Suriname (+597)
Svalbard and Jan Mayen (+47)
Swaziland (+268)
Sweden (+46)
Switzerland (+41)
Syrian Arab Republic (+963)
Taiwan, Province of China (+886)
Tajikistan (+992)
Tanzania, United Republic of (+255)
Thailand (+66)
Timor-Leste (+670)
Togo (+228)
Tokelau (+690)
Tonga (+676)
Trinidad and Tobago (+1868)
Tunisia (+216)
Turkey (+90)
Turkmenistan (+7370)
Turks and Caicos Islands (+1649)
Tuvalu (+688)
Uganda (+256)
Ukraine (+380)
United Arab Emirates (+971)
United Kingdom (+44)
United States (+1)
United States Minor Outlying Islands (+1)
Uruguay (+598)
Uzbekistan (+998)
Vanuatu (+678)
Venezuela (+58)
Viet Nam (+84)
Virgin Islands, British (+1284)
Virgin Islands, U.s. (+1340)
Wallis and Futuna (+681)
Western Sahara (+212)
Yemen (+967)
Zambia (+260)
Zimbabwe (+263)
Security Code
*
:
Submit
List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Circulating Tumor Cells (CTC) Liquid Biopsy
1.2 Key Market Segments
1.2.1 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
1.2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Overview
2.1 Global Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Competitive Landscape
3.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Manufacturers (2019-2024)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Manufacturers (2019-2024)
3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Circulating Tumor Cells (CTC) Liquid Biopsy Sales Sites, Area Served, Product Type
3.6 Circulating Tumor Cells (CTC) Liquid Biopsy Market Competitive Situation and Trends
3.6.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Circulating Tumor Cells (CTC) Liquid Biopsy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain Analysis
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Circulating Tumor Cells (CTC) Liquid Biopsy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Type (2019-2024)
6.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2019-2024)
6.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Price by Type (2019-2024)
7 Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Sales by Application (2019-2024)
7.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) by Application (2019-2024)
7.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2019-2024)
8 Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation by Region
8.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region
8.2 North America
8.2.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 QIAGEN
9.1.1 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.1.4 QIAGEN Business Overview
9.1.5 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy SWOT Analysis
9.1.6 QIAGEN Recent Developments
9.2 Bio-Techne
9.2.1 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.2.4 Bio-Techne Business Overview
9.2.5 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy SWOT Analysis
9.2.6 Bio-Techne Recent Developments
9.3 Precision Medical
9.3.1 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.3.4 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy SWOT Analysis
9.3.5 Precision Medical Business Overview
9.3.6 Precision Medical Recent Developments
9.4 Aviva Systems Biological
9.4.1 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.4.4 Aviva Systems Biological Business Overview
9.4.5 Aviva Systems Biological Recent Developments
9.5 Biocept
9.5.1 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.5.4 Biocept Business Overview
9.5.5 Biocept Recent Developments
9.6 Fluxion Biosciences
9.6.1 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.6.4 Fluxion Biosciences Business Overview
9.6.5 Fluxion Biosciences Recent Developments
9.7 Greiner Bio-One International GmbH
9.7.1 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.7.4 Greiner Bio-One International GmbH Business Overview
9.7.5 Greiner Bio-One International GmbH Recent Developments
9.8 Ikonisys
9.8.1 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.8.4 Ikonisys Business Overview
9.8.5 Ikonisys Recent Developments
9.9 Miltenyi Biotec
9.9.1 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.9.4 Miltenyi Biotec Business Overview
9.9.5 Miltenyi Biotec Recent Developments
9.10 IVDiagnostics
9.10.1 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.10.4 IVDiagnostics Business Overview
9.10.5 IVDiagnostics Recent Developments
9.11 BioFluidica
9.11.1 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.11.4 BioFluidica Business Overview
9.11.5 BioFluidica Recent Developments
9.12 Canopus Medical
9.12.1 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.12.4 Canopus Medical Business Overview
9.12.5 Canopus Medical Recent Developments
9.13 Biolidics
9.13.1 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.13.4 Biolidics Business Overview
9.13.5 Biolidics Recent Developments
9.14 Creativ MicroTech
9.14.1 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.14.4 Creativ MicroTech Business Overview
9.14.5 Creativ MicroTech Recent Developments
9.15 LungLife AI
9.15.1 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.15.4 LungLife AI Business Overview
9.15.5 LungLife AI Recent Developments
9.16 Epic Sciences
9.16.1 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.16.4 Epic Sciences Business Overview
9.16.5 Epic Sciences Recent Developments
9.17 Rarecells Diagnostics
9.17.1 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.17.4 Rarecells Diagnostics Business Overview
9.17.5 Rarecells Diagnostics Recent Developments
9.18 ScreenCell
9.18.1 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.18.4 ScreenCell Business Overview
9.18.5 ScreenCell Recent Developments
9.19 Menarini Silicon Biosystems
9.19.1 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Basic Information
9.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
9.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
9.19.4 Menarini Silicon Biosystems Business Overview
9.19.5 Menarini Silicon Biosystems Recent Developments
10 Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Region
10.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast
10.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
10.2.3 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region
10.2.4 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Circulating Tumor Cells (CTC) Liquid Biopsy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2025-2030)
11.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2025-2030)
11.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Application (2025-2030)
11.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) Forecast by Application
11.2.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings